These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 37993691

  • 1. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F, Ali DS, Almonaei K, Al-Alwani H, Khan AA, Brandi ML.
    Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
    [Abstract] [Full Text] [Related]

  • 2. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 3. A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia.
    Sugiyama Y, Watanabe T, Tajika M, Matsuhashi T, Shimura M, Fushimi T, Ichimoto K, Matsunaga A, Ebihara T, Tsuruoka T, Akiyama T, Murayama K.
    Orphanet J Rare Dis; 2022 Feb 23; 17(1):78. PubMed ID: 35197081
    [Abstract] [Full Text] [Related]

  • 4. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Del Angel G, Zhou S, Rush ET.
    Mol Genet Metab; 2021 May 23; 133(1):113-121. PubMed ID: 33814268
    [Abstract] [Full Text] [Related]

  • 5. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 23; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 7. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 10; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 8. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia.
    Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan WJ.
    J Bone Miner Res; 2024 Sep 26; 39(10):1412-1423. PubMed ID: 39135540
    [Abstract] [Full Text] [Related]

  • 9. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 26; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 10. Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment.
    Seefried L, Genest F, Petryk A, Veith M.
    Bone; 2023 Oct 26; 175():116856. PubMed ID: 37481150
    [Abstract] [Full Text] [Related]

  • 11. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C, Seefried L, Jakob F.
    Drugs Today (Barc); 2016 May 26; 52(5):271-85. PubMed ID: 27376160
    [Abstract] [Full Text] [Related]

  • 12. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
    Stürznickel J, Schmidt FN, von Vopelius E, Delsmann MM, Schmidt C, Jandl NM, Oheim R, Barvencik F.
    Bone; 2021 Feb 26; 143():115794. PubMed ID: 33301963
    [Abstract] [Full Text] [Related]

  • 13. Impressive clinical improvement and disappearance of neuropathic pain in an adult patient with hypophosphatasia treated with asfotase alfa.
    Zervou Z, Plooij R, van Velsen EFS, Timmermans RGM, Demirdas S, Zillikens MC.
    Eur J Med Genet; 2024 Apr 26; 68():104915. PubMed ID: 38325645
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
    Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, Okada S, Fujiwara I, Kokaji M, Mochizuki H, Ogata T, Tatebayashi K, Watanabe A, Yatsuga S, Kubota T, Ozono K.
    Clin Endocrinol (Oxf); 2017 Jul 26; 87(1):10-19. PubMed ID: 28374482
    [Abstract] [Full Text] [Related]

  • 15. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA, Foster BL.
    Drug Des Devel Ther; 2018 Jul 26; 12():3147-3161. PubMed ID: 30288020
    [Abstract] [Full Text] [Related]

  • 16. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May 26; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia.
    Seefried L, Kishnani PS, Moseley S, Denker AE, Watsky E, Whyte MP, Dahir KM.
    Bone; 2021 Jan 26; 142():115664. PubMed ID: 32987199
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review.
    Shirinezhad A, Esmaeili S, Azarboo A, Tavakoli Y, Hoveidaei AH, Zareshahi N, Ghaseminejad-Raeini A.
    Bone; 2024 Nov 26; 188():117219. PubMed ID: 39089608
    [Abstract] [Full Text] [Related]

  • 19. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct 26; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry.
    Kishnani PS, Martos-Moreno GÁ, Linglart A, Petryk A, Messali A, Fang S, Rockman-Greenberg C, Ozono K, Högler W, Seefried L, Dahir KM.
    Orphanet J Rare Dis; 2024 Mar 08; 19(1):109. PubMed ID: 38459585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.